Johnson & Johnson is seeking FDA approval of a multiple myeloma drug that could become the first one addressing a novel target called GPRC5D. Data from the Phase 1/2 study supporting the biologics license application were presented in New Orleans during the annual meeting of the American Society of Hematology.
With the annual INVEST Population Health virtual conference coming up November 16-18, here's a look at our collaboration partner New Orleans Business Alliance. It plays a vital role in helping to stimulate the local economy by supporting the development and advancement of the healthcare and biotech infrastructure.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
After seeing their peers in Washington, and now New York, treat an onslaught of Covid-19 cases, hospitals in communities that haven’t been hit as hard yet are rushing to ready beds, ventilators and other needed equipment. MedCity News interviewed physicians across the U.S. to see how they are preparing for the next wave of the disease.
Louisiana leaders tout three expanding companies while pledging $3M to back a struggling biotech incubator in New Orleans as part of an effort to bolster the state's biotech sector. Meanwhile, a private effort to create a life science incubator is underway in the Bay Area.
With more individuals exploring their family tree, it’s reasonable to believe many of them are als intent to get a handle on their potential for various hereditary diseases. With that in mind, Ochsner Health has launched a digital population health pilot program.
As we get closer to the inaugural MedCity INVEST Population Health conference with the New Orleans Business Alliance May 22, the CEO of Ochsner Health's innovation lab talked about some of the programs the group has developed to support care delivery.
During the May 22 event in New Orleans, the startups — which tackle social determinants of health, behavioral health and more — will present their solutions and vie for the first place prize.
May 22 marks the inaugural MedCity INVEST Pop Health conference in collaboration with the New Orleans Business Alliance. The population health conference is timely as communities around the nation wrestle with how best to help patients manage chronic conditions, reduce hospitalizations, and improve outcomes.
INVEST Pop Health, a collaboration between MedCity News and the New Orleans Business Alliance, will highlight the efforts underway to transform population health and will take place on May 22 at the Louisiana Cancer Research Consortium in New Orleans.
New Orleans-based Ochsner Health System chose Appriss Health to enable integration of Louisiana's prescription drug monitoring program information into its Epic EHR system. Ochsner CMIO Todd Burstain said the service went live in October of 2017.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Humana will enlist Quartet Health to help Medicare Advantage patients in Greater New Orleans grappling with anxiety and depression as comorbidities with chronic health conditions as part of Humana's Bold Goal initiative.
The American Heart Association is collaborating with Amazon Web Services, pharma giant Astra Zeneca and several major research institutes to create the AHA Precision Medicine Platform.
“I think we’re going to hear more about SGLT2 inhibitors because they’re easy for patients to use and for physicians to prescribe,” said conference attendee Athena Philis-Tsimikas corporate vice president of the Scripps Whittier Diabetes Institute.
IBM Watson Health and the ADA also will be running a challenge to spur the development of apps to support people living with or at risk for diabetes.
The Louisiana health system has implemented two digital health programs in the last couple of years to take advantage of patient-generated data.
